Colonoscopy Assisted Laparoscopic Wedge Resection for Colonic Lesions: Impact on Quality of LifE: Results from the LIMERIC Study.

IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Amber G Brink, Julia Hanevelt, Laura W Leicher, Leon M G Moons, Frank P Vleggaar, Jelle F Huisman, Wouter de Vos Tot Nederveen Cappel, Henderik L van Westreenen
{"title":"Colonoscopy Assisted Laparoscopic Wedge Resection for Colonic Lesions: Impact on Quality of LifE: Results from the LIMERIC Study.","authors":"Amber G Brink, Julia Hanevelt, Laura W Leicher, Leon M G Moons, Frank P Vleggaar, Jelle F Huisman, Wouter de Vos Tot Nederveen Cappel, Henderik L van Westreenen","doi":"10.1097/DCR.0000000000003531","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The LIMERIC study has proven that colonoscopy-assisted laparoscopic wedge resection effectively and safely removes benign colonic lesions unsuitable for endoscopic removal, thereby avoiding the need for major surgery.</p><p><strong>Objective: </strong>To evaluate the impact of colonoscopy-assisted laparoscopic wedge on health-related quality of life of patients who participated in the LIMERIC study.</p><p><strong>Design: </strong>Prospective multicenter study.</p><p><strong>Settings: </strong>The LIMERIC study was performed between 2016 and 2020 in 13 Dutch hospitals. EQ-5D-5L questionnaires were administered at baseline and 3 months after the procedure.</p><p><strong>Patients: </strong>Patients with incomplete pre- or postoperative questionnaires or those undergoing combined interventions were excluded from the intention-to-treat analysis. Those for whom CAL-WR was not feasible or who underwent completion surgery were excluded from the per-protocol analysis.</p><p><strong>Intervention: </strong>Colonoscopy-assisted laparoscopic wedge for either (1) colon polyp unsuitable for endoscopic resection; (2) non-lifting residual or recurrent polyp within scar tissue following previous polypectomy; or (3) Rx/R1 endoscopic removal of a low-risk pT1 colon carcinoma.</p><p><strong>Main outcome measures: </strong>Three-month health-related quality of life.</p><p><strong>Results: </strong>Colonoscopy-assisted laparoscopic wedge did not affect health-related quality of life in the per-protocol analysis (n = 56), or in the intention-to-treat analysis (n = 67). The majority of patients reported no change in health status (57%). No significant differences were observed in the distribution of responses across all 5 dimensions before and after colonoscopy-assisted laparoscopic wedge. Patients' self-rated EQ-VAS was also unaffected by colonoscopy-assisted laparoscopic wedge, with a median VAS score of 82.5 at baseline and 80 after surgery in the per-protocol analysis (p = 0.63).</p><p><strong>Limitations: </strong>Solely a patient-reported outcome measure evaluating global health-related quality of life was used, rather than one specifically assessing disease-related quality of life, such as the QLQ-CR29.</p><p><strong>Conclusions: </strong>Colonoscopy-assisted laparoscopic wedge has no significant impact on the health-related quality of life in patients with benign colonic lesions and should therefore be considered before major surgery is performed. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases of the Colon & Rectum","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/DCR.0000000000003531","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The LIMERIC study has proven that colonoscopy-assisted laparoscopic wedge resection effectively and safely removes benign colonic lesions unsuitable for endoscopic removal, thereby avoiding the need for major surgery.

Objective: To evaluate the impact of colonoscopy-assisted laparoscopic wedge on health-related quality of life of patients who participated in the LIMERIC study.

Design: Prospective multicenter study.

Settings: The LIMERIC study was performed between 2016 and 2020 in 13 Dutch hospitals. EQ-5D-5L questionnaires were administered at baseline and 3 months after the procedure.

Patients: Patients with incomplete pre- or postoperative questionnaires or those undergoing combined interventions were excluded from the intention-to-treat analysis. Those for whom CAL-WR was not feasible or who underwent completion surgery were excluded from the per-protocol analysis.

Intervention: Colonoscopy-assisted laparoscopic wedge for either (1) colon polyp unsuitable for endoscopic resection; (2) non-lifting residual or recurrent polyp within scar tissue following previous polypectomy; or (3) Rx/R1 endoscopic removal of a low-risk pT1 colon carcinoma.

Main outcome measures: Three-month health-related quality of life.

Results: Colonoscopy-assisted laparoscopic wedge did not affect health-related quality of life in the per-protocol analysis (n = 56), or in the intention-to-treat analysis (n = 67). The majority of patients reported no change in health status (57%). No significant differences were observed in the distribution of responses across all 5 dimensions before and after colonoscopy-assisted laparoscopic wedge. Patients' self-rated EQ-VAS was also unaffected by colonoscopy-assisted laparoscopic wedge, with a median VAS score of 82.5 at baseline and 80 after surgery in the per-protocol analysis (p = 0.63).

Limitations: Solely a patient-reported outcome measure evaluating global health-related quality of life was used, rather than one specifically assessing disease-related quality of life, such as the QLQ-CR29.

Conclusions: Colonoscopy-assisted laparoscopic wedge has no significant impact on the health-related quality of life in patients with benign colonic lesions and should therefore be considered before major surgery is performed. See Video Abstract.

结肠镜辅助腹腔镜楔形切除术治疗结肠病变:对生活质量的影响:LIMERIC 研究的结果。
背景:LIMERIC研究证明,结肠镜辅助腹腔镜楔形切除术能有效、安全地切除不适合内镜切除的结肠良性病变,从而避免了大手术:评估结肠镜辅助腹腔镜楔形切除术对参与 LIMERIC 研究的患者健康相关生活质量的影响:设计:前瞻性多中心研究:LIMERIC研究于2016年至2020年间在13家荷兰医院进行。在基线和术后 3 个月进行 EQ-5D-5L 问卷调查:意向治疗分析排除了术前或术后问卷不完整的患者或接受联合干预的患者。干预措施:结肠镜辅助腹腔镜手术:干预措施:结肠镜辅助腹腔镜楔形术,用于(1)不适合内镜切除的结肠息肉;(2)先前息肉切除术后瘢痕组织内不移位的残留或复发息肉;或(3)Rx/R1内镜下切除低风险pT1结肠癌:三个月的健康相关生活质量:结果:结肠镜辅助腹腔镜楔形术在按协议分析(n = 56)或意向治疗分析(n = 67)中不影响健康相关生活质量。大多数患者的健康状况没有变化(57%)。结肠镜辅助腹腔镜楔形术前后,患者在所有 5 个方面的反应分布无明显差异。结肠镜辅助腹腔镜楔切术也未影响患者的自我评价 EQ-VAS,在按协议分析中,基线 VAS 中位数为 82.5 分,术后为 80 分(P = 0.63):局限性:该研究仅使用了评估总体健康相关生活质量的患者报告结果,而没有使用专门评估疾病相关生活质量的方法,如 QLQ-CR29:结肠镜辅助腹腔镜楔形术对结肠良性病变患者的健康相关生活质量没有显著影响,因此应在实施大手术前予以考虑。参见视频摘要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
7.70%
发文量
572
审稿时长
3-8 weeks
期刊介绍: Diseases of the Colon & Rectum (DCR) is the official journal of the American Society of Colon and Rectal Surgeons (ASCRS) dedicated to advancing the knowledge of intestinal disorders by providing a forum for communication amongst their members. The journal features timely editorials, original contributions and technical notes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信